Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial

by Vahlquist, A, Blockhuys, S, Steijlen, P, van Rossem, K, Didona, B, Blanco, D, Traupe, H
Published 2014

Tumor necrosis factor polymorphisms in psoriatic arthritis: association with the promoter polymorphism TNF-857 independent of the PSORS1 risk allele

by Reich, K, Hüffmeier, U, König, IR, Lascorz, J, Lohmann, J, Wendler, J, Traupe, H, Mössner, R, Reis, A, Burkhardt, H
Published 2007

Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1

by Hüffmeier, U, Lascorz, J, Becker, T, Schürmeier-Horst, F, Magener, A, Ekici, A B, Endele, S, Thiel, C T, Thoma-Uszynski, S, Mössner, R, Reich, K, Kurrat, W, Wienker, T F, Traupe, H, Reis, A
Published 2009